KindlyMD(R) Announces Third Quarter 2024 Financial Results
KindlyMD(R) Announces Third Quarter 2024 Financial Results
"We are pleased with the progress made during the third quarter to expand our credentialing and increase insurance visits, resulting in a 16.4% growth sequentially. This greatly improves the accessibility of our services, making them available to a broader patient base and allowing financial flexibility for our patients to visit more often," Tim Pickett, PA-C, KindlyMD Founder and CEO, stated. "Our strategic focus on expanding capacity and network has proven our model can achieve in-network status with the largest payers. We can use this status to help grow the number of lives we treat in Utah and beyond. We have also begun to develop enterprise-level data analytics and are excited to drive more personalized and effective care in the fight to improve health outcomes faster and at lower patient cost. We now also have the ability to aggregate and analyze disjointed data from many sources, uncovering drug usage trends, product effectiveness, patient risk factors, and opportunities to enhance therapies."Q3 Reimbursements from insurance payors totaled $106,567 an increase of 16.4% sequentially
保险支付方第三季度报销总额为106,567美元，按季增长16.4%
KindlyMD now provides more than 90% in-network insurance coverage in Utah
KindlyMD现在在犹他州提供超过90%的网络内保险覆盖
SALT LAKE CITY, UT / ACCESSWIRE / November 13, 2024 / ("KindlyMD" or the "Company") (NASDAQ:KDLY), a patient-first healthcare and healthcare data company redefining value-based care and patient-centered medical services, today announced its financial results for the third quarter ended September 30, 2024.
犹他州盐湖城/ ACCESSWIRE/ 2024年11月13日/ ("KindlyMD" 或"公司") (纳斯达克:KDLY)，一个以患者为先的医疗保健和医疗数据公司，正在重新定义以价值为核心的护理和以患者为中心的医疗服务，今天宣布了截至2024年9月30日第三季度的财务业绩。
"We are pleased with the progress made during the third quarter to expand our credentialing and increase insurance visits, resulting in a 16.4% growth sequentially. This greatly improves the accessibility of our services, making them available to a broader patient base and allowing financial flexibility for our patients to visit more often," Tim Pickett, PA-C, KindlyMD Founder and CEO, stated. "Our strategic focus on expanding capacity and network has proven our model can achieve in-network status with the largest payers. We can use this status to help grow the number of lives we treat in Utah and beyond. We have also begun to develop enterprise-level data analytics and are excited to drive more personalized and effective care in the fight to improve health outcomes faster and at lower patient cost. We now also have the ability to aggregate and analyze disjointed data from many sources, uncovering drug usage trends, product effectiveness, patient risk factors, and opportunities to enhance therapies."
"我们对第三季度扩大我们的资格和增加保险就诊次数取得的进展感到满意，导致按季度增长16.4%。这极大地提高了我们服务的可及性，使其面向更广泛的患者群体，并为我们的患者提供了更多访问的财务灵活性，" Tim Pickett, PA-C, KindlyMD创始人兼首席执行官, 表示。"我们战略上聚焦于扩大能力和网络已经证明我们的模式可以与最大的支付方达成网络内地位。我们可以利用这一地位帮助在犹他州和更远的地方增加我们治疗的人数。我们还开始开发企业级数据分析，并且对能够以更加个性化和有效的方式推动改善健康结果的护理充满期待，而且可以以更低的患者成本更快地实现健康结果。我们现在也有能力汇总和分析来自许多来源的不连贯数据，发现药物使用趋势、产品有效性、患者风险因素以及提高疗法的机会。"
Operational Highlights:
经营亮点：
Achieved above 90% statewide insurance coverage in Utah with the addition of the largest health insurer in the United States, United Healthcare Insurance.
Introduced $500,000 share repurchase program to enhance shareholder value.
Recognized as one of the winners of the Healthcare AI Impact Award 2024.
Appointed Jeremy Joyal as Medical Director & Nancy Pratt as Behavioral Health Program Director.
通过与美国最大的健康保险公司美国联合健康保险的合作，实现了犹他州90%以上的全州保险覆盖。
推出50万美元的股份回购计划，以提升股东价值。
被认可为2024年医疗保健人工智能影响奖的获奖者之一。
任命Jeremy Joyal为医疗主任，Nancy Pratt为行为健康项目主任。
Financial Highlights for the Quarterly Period Ended September 30, 2024
The Company earned $106,567 in reimbursements from insurance payers during the three months ended September 30, 2024, representing a 16.4% increase compared to the $91,553 earned during the three months ended June 30, 2024. The Company earned $232,892 in reimbursements from insurance payers during the nine months ended September 30, 2024, and $0 during the three and nine months ended September 30, 2023.
截至2024年9月30日季度结束的财务要点。
公司在2024年9月30日结束的三个月内从保险支付者处获得106,567美元的报销，较2024年6月30日结束的三个月内获得的91,553美元增长了16.4%。公司在2024年9月30日结束的九个月内从保险支付者处获得232,892美元的报销，在2024年9月30日结束的三个月和九个月内没有获得任何报销。
Revenues decreased by $221,401, or 25.5%, to $647,867 for the three months ended September 30, 2024, from $869,268 for the three months ended September 30, 2023. The decrease in revenues is primarily attributed to a decrease in cash-pay patient care services as KindlyMD continues to shift toward insurance billing with commercial and governmental payers including Medicare, Medicaid, Select Health, Blue Cross Blue Shield, Cigna, and other commercial payers compared to the prior period.
营业收入下降221,401美元，或25.5%，至2024年9月30日结束的三个月的647,867美元，而2023年9月30日结束的三个月为869,268美元。营业收入下降主要归因于现金支付患者护理服务的减少，因为KindlyMD继续向商业和政府支付者，包括医疗保险、医疗补助、Select Health、蓝十字蓝盾、Cigna和其他商业支付者转向保险账单与之前期间相比。
During the quarter, the Company generated revenue from service affiliate agreements for the first time. Service affiliate agreement earnings for the period were $22,432.
公司在本季度首次从服务联盟协议中产生收入。该期间的服务联盟协议收入为22,432美元。
Operating expenses increased by $316,820, or 22.9%, to $1,697,685 for the three months ended September 30, 2024, from $1,380,865 for the three months ended September 30, 2023. The increase in operating expenses is primarily attributable to an increase in general and administrative expenses, salaries and wages, and cost of revenues.
营业费用增加了316,820美元，或22.9%，至2024年9月30日结束的三个月的1,697,685美元，而2023年9月30日结束的三个月为1,380,865美元。营业费用增加主要归因于一般和行政开支、工资、收入成本的增加。
Net loss was $1,014,147 for the three months ended September 30, 2024, compared to a net loss of $515,146 for the three months ended September 30, 2023. Net loss per share decreased by $0.06, or 54.5%, to $(0.17) for the three months ended September 30, 2024, compared to $(0.11) for the three months ended September 30, 2023. KindlyMD management strives to look for opportunities to optimize revenue by increasing sales, acquiring additional clinics, improving margins, and controlling ongoing operating expenses.
净亏损为2024年9月30日结束的三个月的1,014,147美元，而2023年9月30日结束的三个月为净亏损515,146美元。每股净亏损减少了0.06美元，或54.5%，至2024年9月30日结束的三个月的-0.17美元，而2013年9月30日结束的三个月为-0.11美元。KindlyMD管理层努力寻求机会通过增加销售、收购额外诊所、提高利润率和控制持续营业费用来优化营业收入。
As of September 30, 2024, the company had cash and cash equivalents of $3,642,944 and total working capital of $3,215,466.
截至2024年9月30日，该公司的现金及现金等价物为3,642,944美元，总营运资本为3,215,466美元。
As of November 8, 2024, the Company had 5,977,476 common shares outstanding.
截至2024年11月8日，公司拥有5,977,476股普通股。
About KindlyMD
KindlyMD is a patient-first healthcare and healthcare data company redefining value-based care and patient-centered medical services. Kindly MD leverages data analysis to deliver evidence-based, personalized solutions in order to reduce opioid use, improve health outcomes faster, and provide algorithmic guidance on the use of alternative medicine in healthcare. We collect and analyze valuable data on alternative treatments as well as biopsychosocial factors to provide better health outcomes faster. This results in valuable data for patients, the company, and the company's investors as we aim to become a leading source of evidence-based assessment and treatment data in the fight for patients against the opioid epidemic and as we strive to be a leader in redefined value-based care.
关于KindlyMD
KindlyMD是一家以患者为中心的医疗保健和医疗数据公司，重新定义价值为本护理和以患者为中心的医疗服务。Kindly MD利用数据分析提供基于证据的个性化解决方案，以减少阿片类药物的使用，更快地提高健康结果，并在医疗保健中提供替代药物使用的算法指导。我们收集并分析有关替代治疗以及生物—心理—社会因素的宝贵数据，以更快地实现更好的健康结果。这将为患者、公司和公司的投资者提供宝贵的数据，因为我们致力成为抗击阿片类药物危机的主要基于证据的评估和治疗数据来源，并努力成为重新定义的价值为本护理领域的领军者。
KindlyMD provides a patient-focused healthcare experience that integrates traditional medical evaluation and management with mental health integration and compliant alternative medicine education and inclusion. We focus on creating personalized care plans for each individual that get people back to work and life faster, reduce opioid use, and have high patient satisfaction.
KindlyMD提供以患者为中心的医疗体验，整合传统医学评估和管理与心理健康整合以及合规的替代医学教育和包容。我们专注于为每个个体创建个性化护理计划，让人们更快地重返工作和生活，减少阿片类药物的使用，并获得高满意度。
Its specialty outpatient clinical services are reimbursed by Medicare, Medicaid, and commercial insurance contracts as well as offered on a fee-for-service basis. For more information, please visit .
其专科门诊临床服务通过医疗保险、医疗补助和商业保险合同以及按服务收费的方式获得报销。欲了解更多信息，请访问。
Forward-Looking Statements
This press release contains certain forward-looking statements that are based upon current expectations and involve certain risks and uncertainties within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements can be identified by the use of words such as "should," "may," "intends," "anticipates," "believes," "estimates," "projects," "forecasts," "expects," "plans," and "proposes." These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. You are urged to carefully review and consider any cautionary statements and other disclosures, including the statements made under the heading "Risk Factors" in KindlyMD, Inc.'s Annual Report on Form 10-K for the fiscal year ended December 31, 2022. KindlyMD, Inc. does not undertake any duty to update any forward-looking statements except as may be required by law. The information which appears on our websites and our social media platforms, including, but not limited to, Instagram and Facebook, is not part of this press release.
前瞻性声明
本新闻稿包含基于当前预期并涉及美国1995年《私人证券诉讼改革法案》意义内的一些风险和不确定性的前瞻性声明。此类前瞻性声明可以通过使用诸如“应该”、“可能”、“打算”、“预期”、“相信”、“估计”、“项目”、“预测”、“期望”、“计划”和“建议”等词语来识别。这些前瞻性声明不是对未来绩效的保证，并且受到风险、不确定性和其他一些超出我们控制和难以预测的因素的影响，会导致实际结果与前瞻性声明中表达或预测的有所不同。我们建议您仔细审查和考虑任何警示性声明和其他披露，包括在KindlyMD股东会年度报告（截至2022年12月31日财政年度的Form 10-K表格）栏目下所做的声明。KindlyMD股东会不承担除法律规定外的任何更新前瞻性声明的责任。出现在我们网站和社交媒体平台上的信息，包括但不限于Instagram和Facebook的信息，不是本新闻稿的一部分。
KINDLY MD, INC.
CONDENSED BALANCE SHEETS
KINDLY MD, INC.
简明资产负债表
September 30, 2024 |
December 31, 2023 |
|||||||
(Unaudited) |
||||||||
ASSETS |
||||||||
Current Assets |
||||||||
Cash and cash equivalents |
$ |
3,642,944 |
$ |
525,500 |
||||
Accounts receivable |
45,323 |
28,001 |
||||||
Inventories, net |
2,750 |
63,202 |
||||||
Prepaid expenses and other current assets |
250,316 |
225 |
||||||
Total Current Assets |
3,941,333 |
616,928 |
||||||
Property and equipment, net |
183,349 |
235,292 |
||||||
Operating lease right-of-use assets |
188,204 |
235,706 |
||||||
Security deposits |
11,276 |
11,276 |
||||||
TOTAL ASSETS |
$ |
4,324,162 |
$ |
1,099,202 |
||||
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) |
||||||||
Current Liabilities |
||||||||
Accounts payable and accrued expenses |
$ |
431,516 |
$ |
329,810 |
||||
Customer deposits |
2,750 |
3,425 |
||||||
Current portion of operating lease liabilities |
100,982 |
94,696 |
||||||
Current portion of finance lease liabilities |
2,020 |
- |
||||||
Current portion of notes payable, net |
188,599 |
148,517 |
||||||
Derivative liability |
- |
238,000 |
||||||
Total Current Liabilities |
725,867 |
814,448 |
||||||
Operating lease liabilities, net of current portion |
106,114 |
164,295 |
||||||
Finance lease liabilities, net of current portion |
8,126 |
|||||||
Notes payable, net of current portion |
- |
228,871 |
||||||
TOTAL LIABILITIES |
840,107 |
1,207,614 |
||||||
Stockholders' Equity (Deficit) |
||||||||
Preferred Stock, $0.001 par value, 10,000,000 shares authorized; none issued and outstanding as of September 30, 2024 and December 31, 2023 |
- |
- |
||||||
Common stock, $0.001 par value, 100,000,000 shares authorized; 5,977,476 and 4,617,798 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively |
5,977 |
4,618 |
||||||
Additional paid-in capital |
10,252,258 |
4,045,024 |
||||||
Accumulated deficit |
(6,774,180) | (4,158,054) | ||||||
TOTAL STOCKHOLDERS' EQUITY (DEFICIT) |
3,484,055 |
(108,412) | ||||||
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) |
$ |
4,324,162 |
$ |
1,099,202 |
||||
2024年9月30日 |
2023年12月31日 |
|||||||
(未经审计) |
||||||||
资产 |
||||||||
流动资产 |
||||||||
现金及现金等价物 |
$ |
3,642,944 |
$ |
525,500 |
||||
应收账款 |
45,323 |
28,001 |
||||||
净存货 |
2,750 |
63,202 |
||||||
预付费用及其他流动资产 |
250,316 |
225 |
||||||
流动资产合计 |
3,941,333 |
616,928 |
||||||
物业和设备，净值 |
183,349 |
235,292 |
||||||
经营租赁使用权资产 |
188,204 |
235,706 |
||||||
保证金 |
11,276 |
11,276 |
||||||
资产总计 |
$ |
4,324,162 |
$ |
1,099,202 |
||||
负债和股东权益(赤字) |
||||||||
流动负债 |
||||||||
应付账款和应计费用 |
$ |
431,516 |
$ |
329,810 |
||||
客户存款 |
2,750 |
3,425 |
||||||
经营租赁负债流动部分 |
100,982 |
94,696 |
||||||
融资租赁负债的流动部分 |
2,020 |
- |
||||||
应付票据的流动部分，净额 |
188,599 |
148,517 |
||||||
衍生负债 |
- |
|
||||||
总流动负债 |
725,867 |
814,448 |
||||||
经营租赁负债，净值超过流动资产 |
106,114 |
164,295 |
||||||
金融租赁负债，减去流动部分 |
8,126 |
|||||||
应付款项-净额 |
- |
228,871 |
||||||
负债合计 |
840,107 |
1,207,614 |
||||||
股东权益(赤字) |
||||||||
优先股，面值$0.001，授权10,000,000股；截至2024年9月30日和2023年12月31日，均未发行和流通。 |
- |
- |
||||||
普通股，面值$0.001，授权100,000,000股；截至2024年9月30日和2023年12月31日，分别发行和流通5,977,476股和4,617,798股。 |
5,977 |
4,618 |
||||||
追加实收资本 |
10,252,258 |
4,045,024 |
||||||
累积赤字 |
(6,774,180) | (4,158,054) | ||||||
股东权益合计（亏损） |
3,484,055 |
(108,412) | ||||||
总负债和股东权益（赤字） |
$ |
4,324,162 |
$ |
1,099,202 |
||||
KINDLY MD, INC.
CONDENSED STATEMENTS OF OPERATIONS
(UNAUDITED)
KINDLY MD, INC.
捷凯收购公司二期有限公司
(未经审计)
For the Three Months Ended |
For the Nine Months Ended |
|||||||||||||||
2024 |
2023 |
2024 |
2023 |
|||||||||||||
Revenues |
$ |
647,867 |
$ |
869,268 |
$ |
2,115,953 |
$ |
3,009,151 |
||||||||
Operating Expenses |
||||||||||||||||
Cost of revenues |
7,790 |
20,224 |
77,481 |
128,356 |
||||||||||||
Salaries and wages |
1,138,561 |
995,078 |
2,973,420 |
3,037,938 |
||||||||||||
General and administrative |
525,758 |
339,559 |
1,312,980 |
1,083,278 |
||||||||||||
Depreciation |
25,576 |
26,004 |
76,210 |
77,670 |
||||||||||||
Total Operating Expenses |
1,697,685 |
1,380,865 |
4,440,091 |
4,327,242 |
||||||||||||
LOSS FROM OPERATIONS |
(1,049,818) | (511,597) | (2,324,138) | (1,318,091) | ||||||||||||
Other Income (Expenses) |
||||||||||||||||
Other income |
45,330 |
9,001 |
71,198 |
46,302 |
||||||||||||
Interest expense |
(9,659) | (12,550) | (385,348) | (20,744) | ||||||||||||
Loss on extinguishment of debt |
- |
- |
(38,889) | - |
||||||||||||
Gain on change in fair value of derivative liability |
- |
- |
61,051 |
- |
||||||||||||
Total Other Income (Expenses) |
35,671 |
(3,549) | (291,988) | 25,558 |
||||||||||||
NET LOSS BEFORE INCOME TAXES |
(1,014,147) | (515,146) | (2,616,126) | (1,292,533) | ||||||||||||
INCOME TAX EXPENSE |
- |
- |
- |
- |
||||||||||||
NET LOSS |
$ |
(1,014,147) | $ |
(515,146) | $ |
(2,616,126) | $ |
(1,292,533) | ||||||||
LOSS PER COMMON SHARE - BASIC AND DILUTED |
$ |
(0.17) | $ |
(0.11) | $ |
(0.50) | $ |
(0.29) | ||||||||
WEIGHTED-AVERAGE NUMBER OF SHARES OUTSTANDING - BASIC AND DILUTED |
5,944,590 |
4,521,242 |
5,193,533 |
4,445,714 |
||||||||||||
截至三个月结束 |
截至九月三十日的九个月 |
|||||||||||||||
2024 |
2023 |
2024 |
2023 |
|||||||||||||
收入 |
$ |
647,867 |
$ |
869,268 |
$ |
2,115,953 |
$ |
3,009,151 |
||||||||
运营费用 |
||||||||||||||||
收入成本 |
7,790 |
20,224 |
77,481 |
128,356 |
||||||||||||
工资薪金 |
1,138,561 |
995,078 |
2,973,420 |
3,037,938 |
||||||||||||
一般和行政 |
525,758 |
339,559 |
1,312,980 |
1,083,278 |
||||||||||||
折旧费 |
25,576 |
26,004 |
76,210 |
77,670 |
||||||||||||
总营业费用 |
1,697,685 |
1,380,865 |
4,440,091 |
4,327,242 |
||||||||||||
营业亏损 |
(1,049,818) | (511,597) | (2,324,138) | (1,318,091) | ||||||||||||
其他收入（支出） |
||||||||||||||||
其他收入 |
45,330 |
9,001 |
71,198 |
46,302 |
||||||||||||
利息支出 |
(9,659) | (12,550) | (385,348) | (20,744) | ||||||||||||
债务摊销损失 |
- |
- |
(38,889) | - |
||||||||||||
衍生负债公允价值变动损益收益 |
- |
- |
61,051 |
- |
||||||||||||
其他收入（支出）总额 |
35,671 |
(3,549) | (291,988) | 25,558 |
||||||||||||
税前净亏损 |
(1,014,147) | (515,146) | (2,616,126) | (1,292,533) | ||||||||||||
所得税费用 |
- |
- |
- |
- |
||||||||||||
净损失 |
$ |
(1,014,147) | $ |
(515,146) | $ |
(2,616,126) | $ |
(1,292,533) | ||||||||
每股普通股损失-基本和稀释 |
$ |
（0.17） | $ |
(0.11) | $ |
(0.50) | $ |
(0.29) | ||||||||
基本和稀释后的加权平均股本数 |
5,944,590 |
4,521,242 |
5,193,533 |
4,445,714 |
||||||||||||
KINDLY MD, INC.
CONDENSED STATEMENTS OF CASH FLOWS
(UNAUDITED)
KINDLY MD, INC.
精简现金流量表
(未经审计)
For the Nine Months Ended |
||||||||
2024 |
2023 |
|||||||
CASH FLOWS FROM OPERATING ACTIVITIES |
||||||||
Net loss |
$ |
(2,616,126) | $ |
(1,292,533) | ||||
Adjustments to reconcile net loss to net cash used in operating activities: |
||||||||
Stock-based compensation |
132,994 |
719,169 |
||||||
Depreciation expense |
76,210 |
77,670 |
||||||
Loss on extinguishment of debt |
38,889 |
- |
||||||
Gain on change in fair value of derivative liability |
(61,051) | - |
||||||
Amortization of debt discounts |
367,046 |
1,912 |
||||||
Amortization of right-of-use assets |
75,226 |
52,415 |
||||||
Changes in operating assets and liabilities: |
||||||||
Accounts receivable |
(17,322) | 4,161 |
||||||
Inventories |
60,452 |
(47,131) | ||||||
Prepaid expenses and other current assets |
(250,091) | 33,398 |
||||||
Security deposits |
- |
3,229 |
||||||
Accounts payable and accrued expenses |
101,706 |
262,667 |
||||||
Customer deposits |
(675) | (2,050) | ||||||
Operating lease liabilities |
(79,619) | (53,713) | ||||||
Net cash used in operating activities |
(2,172,361) | (240,806) | ||||||
CASH FLOWS FROM INVESTING ACTIVITIES |
||||||||
Purchases of property and equipment |
(13,291) | (14,420) | ||||||
Net cash used in investing activities |
(13,291) | (14,420) | ||||||
CASH FLOWS FROM FINANCING ACTIVITIES |
||||||||
Net proceeds from issuance of notes payable |
45,000 |
- |
||||||
Net proceeds from issuance of related party note payable |
- |
250,373 |
||||||
Net proceeds from issuance of common shares and warrants in connection with a public offering |
5,860,650 |
- |
||||||
Repayments of related party note payable |
- |
(30,820) | ||||||
Repayments of notes payable |
(601,724) | - |
||||||
Repayments of finance lease liabilities |
(830) | - |
||||||
Net cash provided by financing activities |
5,303,096 |
219,553 |
||||||
NET CHANGE IN CASH AND CASH EQUIVALENTS |
3,117,444 |
(35,673) | ||||||
CASH AND CASH EQUIVALENTS |
||||||||
Beginning of the period |
525,500 |
186,918 |
||||||
End of the period |
$ |
3,642,944 |
$ |
151,245 |
||||
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION |
||||||||
Cash paid for interest |
$ |
19,177 |
$ |
16,133 |
||||
Cash paid for income taxes |
$ |
- |
$ |
- |
||||
NON-CASH INVESTING AND FINANCING ACTIVITIES |
||||||||
Debt discounts on notes payable |
$ |
10,556 |
$ |
- |
||||
Debt discount on related party note payable |
$ |
- |
$ |
16,627 |
||||
Fair value of derivative liability recognized upon issuance of notes payable |
$ |
38,000 |
$ |
- |
||||
Extinguishment of derivative liability upon settlement of notes payable |
$ |
214,949 |
$ |
- |
||||
Finance purchases of property and equipment |
$ |
10,976 |
$ |
- |
||||
Operating lease right-of-use asset and liability measurement |
$ |
27,724 |
$ |
- |
||||
截至九月三十日的九个月 |
||||||||
2024 |
2023 |
|||||||
经营活动产生的现金流量 |
||||||||
净亏损 |
$ |
(2,616,126) | $ |
(1,292,533) | ||||
调整为净损失到经营活动现金流量净使用： |
||||||||
基于股票的补偿 |
132,994 |
719,169 |
||||||
折旧费用 |
76,210 |
77,670 |
||||||
债务摊销损失 |
38,889 |
- |
||||||
衍生负债公允价值变动损益收益 |
(61,051) | - |
||||||
债务贴现摊销 |
367,046 |
1,912 |
||||||
摊销租赁权资产 |
75,226 |
52,415 |
||||||
运营资产和负债的变化： |
||||||||
应收账款 |
(17,322) | 4,161 |
||||||
存货 |
60,452 |
(47,131) | ||||||
预付费用及其他流动资产 |
(250,091) | 33,398 |
||||||
保证金 |
- |
3,229 |
||||||
应付账款和应计费用 |
101,706 |
262,667 |
||||||
客户存款 |
(675) | (2,050) | ||||||
营运租赁负债 |
(79,619) | (53,713) | ||||||
用于经营活动的净现金 |
(2,172,361) | (240,806) | ||||||
投资活动产生的现金流量 |
||||||||
购买物业和设备 |
(13,291) | (14,420) | ||||||
投资活动中使用的净现金 |
(13,291) | (14,420) | ||||||
筹资活动产生的现金流量 |
||||||||
发行应付票据的净收益 |
45,000 |
- |
||||||
与相关方债务票据发行有关的净收入 |
- |
250,373 |
||||||
与公开发行相关的普通股和认股权证净收入 |
5,860,650 |
- |
||||||
相关方债务票据的偿还 |
- |
(30,820) | ||||||
还款应付票据 |
(601,724) | - |
||||||
偿还融资租赁负债 |
(830) | - |
||||||
融资活动提供的净现金 |
5,303,096 |
219,553 |
||||||
现金及现金等价物的净变动 |
3,117,444 |
(35,673) | ||||||
现金及现金等价物 |
||||||||
期初 |
525,500 |
186,918 |
||||||
期末 |
$ |
3,642,944 |
$ |
151,245 |
||||
现金流量补充资料 |
||||||||
支付的利息现金 |
$ |
19,177 |
$ |
16,133 |
||||
支付的所得税费用 |
$ |
- |
$ |
- |
||||
非现金投融资活动 |
||||||||
应付票据的债务折扣 |
$ |
10,556 |
$ |
- |
||||
关联方应付票据的债务折让 |
$ |
- |
$ |
16,627 |
||||
发行应付票据时确认的衍生负债的公允价值 |
$ |
38,000 |
$ |
- |
||||
在结算应付票据时熄灭衍生负债 |
$ |
214,949 |
$ |
- |
||||
为财务购买资产和设备 |
$ |
10,976 |
$ |
- |
||||
经营租赁权利资产和负债的计量 |
$ |
27,724 |
$ |
- |
||||
Contact Information
Valter Pinto
Managing Director, KCSA
kindlymd@kcsa.com
(212) 896-1254
联系信息
Valter Pinto
KCSA管理董事
kindlymd@kcsa.com
(212) 896-1254
SOURCE: KindlyMD, Inc.
来源：KindlyMD，Inc。
